Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 24,841 |
|
|||||
| News | - | ||||||
| Day High | 10.39 | Low High |
|||||
| Day Low | 9.6329 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Avalo Therapeutics Inc | AVTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.75 | -7.22% | 9.64 | 19:51:28 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 10.18 | 9.6329 | 10.39 | 9.64 | 10.39 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 574 | 24,841 | $ 10.06 | $ 249,996 | - | 3.9501 - 1,130.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:42:43 | 50 | $ 10.12 | USD |
Avalo Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.35M | 801.61k | - | 1.92M | -31.54M | -39.35 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Avalo Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AVTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.87 | 12.71 | 9.58 | 10.80 | 51,570 | -2.23 | -18.79% |
| 1 Month | 13.62 | 17.49 | 9.58 | 13.37 | 70,447 | -3.98 | -29.22% |
| 3 Months | 4.26 | 34.46 | 4.20 | 19.33 | 714,441 | 5.38 | 126.29% |
| 6 Months | 23.472 | 34.46 | 3.9501 | 14.94 | 7,737,308 | -13.83 | -58.93% |
| 1 Year | 662.40 | 1,130.40 | 3.9501 | 33.33 | 23,494,246 | -652.76 | -98.54% |
| 3 Years | 688.80 | 1,711.20 | 3.9501 | 39.32 | 8,793,622 | -679.16 | -98.60% |
| 5 Years | 688.80 | 1,711.20 | 3.9501 | 39.32 | 8,793,622 | -679.16 | -98.60% |
Avalo Therapeutics Description
| Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006. |
